Difficulty: Medium
Average Score: 74%
Practice
A 34-year-old man who recently had a renal transplant presents to clinic for follow-up. He has been feeling well and has no specific complaints. His laboratory test results look normal other than an elevated blood glucose of 197 mg/dL. The physician believes the elevated blood glucose may be caused by a medication. What is the most likely medication to cause hyperglycemia?
Correct answer
D
Rationale
In this scenario, the most likely medication to cause hyperglycemia in a renal transplant patient is Tacrolimus (Option D). Tacrolimus is known to be associated with new-onset diabetes after transplantation (NODAT) due to its adverse effect on glucose metabolism. This drug can lead to insulin resistance and impaired insulin secretion, resulting in elevated blood glucose levels.
Azathioprine (Option A) is not typically associated with causing hyperglycemia. While Cyclosporine (Option B) can cause nephrotoxicity and hypertension, it is not a primary culprit for hyperglycemia in this case. Muromonab (Option C) is an immunosuppressive monoclonal antibody that is not commonly linked to hyperglycemia.
In an educational context, understanding the potential side effects of medications used in transplant patients is crucial for nurses to provide comprehensive care. It is essential to recognize the adverse effects of immunosuppressants like Tacrolimus, including their impact on glucose metabolism, to monitor patients effectively and prevent complications such as NODAT. Nurses must be knowledgeable about medication side effects to ensure patient safety and well-being in the post-transplant period.
Azathioprine (Option A) is not typically associated with causing hyperglycemia. While Cyclosporine (Option B) can cause nephrotoxicity and hypertension, it is not a primary culprit for hyperglycemia in this case. Muromonab (Option C) is an immunosuppressive monoclonal antibody that is not commonly linked to hyperglycemia.
In an educational context, understanding the potential side effects of medications used in transplant patients is crucial for nurses to provide comprehensive care. It is essential to recognize the adverse effects of immunosuppressants like Tacrolimus, including their impact on glucose metabolism, to monitor patients effectively and prevent complications such as NODAT. Nurses must be knowledgeable about medication side effects to ensure patient safety and well-being in the post-transplant period.